PALATIN TECHNOLOGIES

We are a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Our programs are based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Our primary product in clinical development is bremelanotide for the treatment of female sexual dysfunction (FSD). In addition, we have drug candidates or development programs for obesity, erectile dysfunction, pulmonary diseases, cardiovascular diseases and inflammatory diseases. The following drug development programs are actively under development:

#People #Financial #Website #More

PALATIN TECHNOLOGIES

Social Links:

Facebook

Twitter

Industry:

Biotechnology Health Care Therapeutics

Founded:

1986-01-01

Address:

Cranbury, New Jersey, United States

Country:

United States

Website Url:

http://www.palatin.com

Total Employee:

11+

Status:

Active

Contact:

609-495-2200

Email Addresses:

[email protected]

Total Funding:

104.2 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins Global Site Tag

Current Employees Featured

carl-spana_image

Carl Spana
Carl Spana CEO & Pres @ Palatin Technologies
CEO & Pres

not_available_image

Jeffrey D. Edelson
Jeffrey D. Edelson Chief Medical Officer @ Palatin Technologies
Chief Medical Officer

not_available_image

Stephen T. Wills
Stephen T. Wills Chief Financial Officer and Chief Operating Officer @ Palatin Technologies
Chief Financial Officer and Chief Operating Officer

Founder

carl-spana_image

Carl Spana

Stock Details

Company's stock symbol is NYSE:PTN

Investors List

qvt-financial_image

Official Site Inspections

http://www.palatin.com Semrush global rank: 4.17 M Semrush visits lastest month: 2.85 K

Host Informations
Whois Informations

Loading ...